PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Barbiturates”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 469 records · Page 26Linked to original sources

Different relations between infarct size and occluded bed size in barbiturate-anesthetized versus conscious dogs.

The relation between infarct size and occluded bed size in barbiturate-anesthetized (n = 32) and conscious (n = 34) dogs was compared using models of the left anterior descending (n = 43) and circumflex (n = 23) coronary arteries with 2 day old infarcts. Infarct and occluded bed (postmortem coronary arteriography) masses were measured by computerized planimetry of weighed left ventricular rings. For either type of occlusion, infarcts were larger in anesthetized than in conscious dogs (56 versus 33% occluded bed, p less than 0.001), with greater slopes of the linear regressions between infarct size and occluded bed size (p less than 0.001) and less epicardial sparing (p less than 0.05) on topographic mapping. Although arterial and left atrial pressures were similar in the two groups, heart rates were higher in the anesthetized dogs, both before (127 versus 88 beats/min, p less than 0.001) and after (151 versus 109 beats/min, p less than 0.001) occlusion. Myocardial blood flow distribution (radioactive microspheres, n = 33) favored the epicardium in anesthetized dogs, with lower endocardial-epicardial flow ratios pre- and postocclusion. Also, the level of total plasma catecholamines (radioenzymatic assay) was higher in barbiturate-anesthetized (n = 5) than in conscious (n = 5) dogs. Increasing the heart rate in conscious dogs (n = 18) to that of the anesthetized group (139 beats/min) by pacing produced larger infarcts and greater linear regression slopes, as seen in anesthetized dogs. Decreasing the heart rate in anesthetized dogs (n = 7) to that of the conscious group (98 beats/min) by sinoatrial node destruction and pacing resulted in smaller infarcts and lower linear regression slope, as seen in conscious dogs. Thus, the larger infarcts in barbiturate-anesthetized dogs appeared to be related mainly to the tachycardia, although transmural maldistribution of flow and increased circulating catecholamines might have contributed.

Analysis of Variance↗

Spectrophotometric reaction rate method for determination of barbituric acid by inhibition of the hydrochloric acid-bromate reaction.

A new kinetic-spectrophotometric method was developed for the determination of barbituric acid. The method is based on its inhibition effect on the reaction between hydrochloric acid and bromate. The decolorization of methyl orange by the reaction products was used to monitor the reaction spectrophotometrically at 510 nm. The variable affecting the rate of the reaction was investigated. The method is simple, rapid, relatively sensitive and precise. The limit of detection is 7.9x10(-7) M and calibration rang is 1x10(-6)-6.0x10(-4) M barbituric acid. The linearity range of the calibration graph is depends on bromate concentration. The relative standard deviation of seven replication determination of 5.6x10(-6) M barbituric acid was 1.8%. The influence of potential interfering substance was studied.

Barbiturates↗

Synthesis of conjugates for a barbiturate screening assay.

Novel derivatives of barbiturates functionalized with free carboxylic acids were designed and synthesized. Coupling of 5-cyclopentyl-5-carboxycrotylbarbituric acid via its active ester to an aminofluorescein derivative produced a fluorescent tracer. Conjugation of the 5-cyclopentenyl-5-carboxyethylbarbituric acid via its mixed anhydride to thyroglobulin allowed for subsequent development of a polyclonal antibody which was evaluated for binding in a fluorescence polarization immunoassay format with various barbiturates. The binding studies showed good cross-reactivity of a variety of barbiturates containing both aromatic and aliphatic 5-substituents with the tested antisera. The relationship between the immunogen architecture, the chemical structure of the binding analytes, and the characteristics of the antisera is also presented.

Animals↗

Artificial receptor-attached amphiphilic copolymer for barbiturate binding in aqueous media.

A water-soluble self-associating amphiphilic copolymer was employed to provide a microenvironment for the solvation of a hydrogen-bonding barbiturate artificial receptor, to facilitate molecular recognition in water. The receptor-attached amphiphilic polymer (RP) was synthesized through random copolymerization of 3% (mol) barbiturate receptor-monomer, 70% (mol) 3-sulfopropyl methacrylate, and 27% (mol) n-dodecyl acrylate. Difference UV spectra of pH 6.5 aqueous solutions of phenobarbital and receptor-polymer (RP) gave peaks and valleys at 272 and 301 nm respectively, consistent with binding characteristics of monomeric barbiturate receptors in chloroform. Specific association between phenobarbital and the receptor-polymer was further indicated based on investigations of a receptor-free control polymer (CP) of similar polar/nonpolar monomer ratio. Micellar electrokinetic chromatography was applied for studying polymer-phenobarbital association, by capillary electrophoresis.

Barbiturates↗

Brain pH in focal cerebral ischemia and the protective effects of barbiturate anesthesia.

Intracellular brain pH was measured with a lipid-soluble, pH-sensitive fluorescent indicator in 16 squirrel monkeys. Eight of these were under halothane anesthesia and eight under barbiturate anesthesia. Measurements were taken before, during, and after focal incomplete ischemia. Brain pH following 3 h of cerebral focal ischemia changed from a normal value of 7.0 to 6.5 and 6.2 in animals studied under barbiturate and halothane anesthesia, respectively. Brain pH returned toward normal after flow was restored in animals under barbiturate anesthesia but continued to deteriorate in animals under halothane anesthesia.

Animals↗

Barbiturate coma for intracranial hypertension: clinical observations.

PURPOSE: To determine the neurologic outcome of patients with intracranial hypertension treated with barbiturate-induced coma. MATERIALS AND METHODS: The records of 49 patients who were admitted to a 31-bed medicosurgical intensive care unit over a 5-year period in whom a barbiturate coma was induced to control intracranial hypertension were analyzed retrospectively. Analysis included assessment of the response to barbiturate coma and evaluation of the long-term neurologic outcome according to the Glasgow Outcome Scale (GOS). RESULTS: Intracranial hypertension was caused by head trauma in 28 patients and subarachnoid hemorrhage in 21 patients. Eight of the head trauma patients and 5 of the patients with subarachnoid hemorrhage survived their hospital stay. The survivors were younger than the nonsurvivors, and had a good neurologic status after 1 year (except for 2 patients who died 1 and 3 months after discharge, respectively). There was no significant difference in the Glasgow Coma Score (GCS) on admission between the survivors and the nonsurvivors. The long-term outcome at 1 year was markedly better in the patients who had experienced a subarachnoid hemorrhage than in the trauma patients.

Adolescent↗

The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium.

In a previous publication (He, J.-S., and Fulco, A. J. (1991) J. Biol. Chem. 266, 7864-7869), we reported that a 15-17-base pair DNA sequence (designated a Barbie box element) in the 5'-regulatory regions of cytochrome P450BM-1 and P450BM-3 genes from Bacillus megaterium was recognized by a barbiturate-regulated protein. It is now recognized that essentially all eukaryotic and prokaryotic genes whose 5'-flanking regions are known and that encode barbiturate-inducible proteins contain the Barbie box element. A 4-base pair sequence (AAAG) is found in the same relative position in all Barbie box elements. In B. megaterium, mutation of the Barbie box located in the P450BM-1 gene leads to the constitutive synthesis of cytochrome P450BM-1 and a 10-fold increase of expression of Bm1P1, a small gene located upstream of the P450BM-1 gene, that encodes a putative regulatory protein. Mutation of the P450BM-3 Barbie box significantly increased the expression of both P450BM-3 and Bm3P1 (another small gene located upstream of the P450BM-3 gene that encodes a second putative regulatory protein) in response to pentobarbital induction but left the basal levels unaffected. In gel mobility shift assays, Bm3R1, a repressor of the P450BM-3 gene, was found to specifically interact with the Barbie box sequences of the B. megaterium P450 genes. Mutated Barbie boxes showed a decreased binding affinity for Bm3R1 compared to their wild type (unmutated) counterparts. Barbie box sequences were also shown to specifically interact with putative positive regulatory factors of B. megaterium cells. These putative positive factors were induced by pentobarbital and were also present at high levels during late stationary phase of B. megaterium cell cultures grown in the absence of barbiturates. The mutated Barbie box sequences had greater binding affinity for these positive factors than did unmutated Barbie box sequences. DNase I footprinting analysis of the 5'-flanking region of the P450BM-1 gene revealed that these positive factors protected a segment of DNA covering a portion of the Barbie box sequence and a small flanking region. Similar footprinting experiments with the 5'-flanking region of the P450BM-3 gene failed, however, to unambiguously reveal protected sequences in the Barbie box region. The evidence suggests that the positive factors and Bm3R1 compete with each other for binding to the Barbie box region, especially in the 5'-flanking region of the P450BM-1 gene, and for putative roles in the regulation of transcription from the B. megaterium P450 genes.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗

Barbiturates block sodium and potassium conductance increases in voltage-clamped lobster axons.

Sodium pentobarbital and sodium thiopental decrease both the peak initial (Na) and late steady-state (K) currents and reduce the maximum sodium and potassium conductance increases in voltage-clamped lobster giant axons. These barbiturates also slow the rate at which the sodium conductance turns on, and shift the normalized sodium conductance vs. voltage curves in the direction of depolarization along the voltage axis. Since pentobarbital (pK(a) = 8.0) blocks the action potential more effectively at pH 8.5 than at pH 6.7, the anionic form of the drug appears to be active. The data suggest that these drugs affect the axon membrane directly, rather than secondarily through effects on intermediary metabolism. It is suggested that penetration of the lipid layer of the membrane by the nonpolar portion of the barbiturate molecules may cause the decrease in membrane conductances, while electrostatic interactions involving the anionic group on the barbiturate, divalent cations, and "fixed charges" in the membrane could account for the slowing of the rate of sodium conductance turn-on and the shift of the normalized conductance curves along the voltage axis.

Action Potentials↗

The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of barbiturates in the control of intracranial hypertension.

High-dose barbiturate therapy is efficacious in lowering ICP and decreasing mortality in the setting of uncontrollable ICP refractory to all other conventional medical and surgical ICP-lowering treatments. Utilization of barbiturates for the prophylactic treatment of ICP is not indicated. The potential complications attendant on this form of therapy mandate that its use be limited to critical care providers and that appropriate systemic monitoring be undertaken to avoid or treat any hemodynamic instability. When barbiturate coma is utilized, consideration should also be given to monitoring arteriovenous oxygen saturation as some patients treated in this fashion may develop oligemic cerebral hypoxia.

Barbiturates↗

Ultraviolet spectrophotometric analysis of barbiturates. Current assessment as an emergency screening procedure.

Several laboratory methods are currently available for the detection of barbiturates, but few are suitable for emergency use, The authors evaluated use of an ultraviolet spectrophotometric method as a screening procedure and compared the results with results obtained by other barbiturate methods (colorimetric, gas-liquid chromatographic, and immunochemical), Procedure time was approximately 40 minutes, sensitivity 0.2 mg/dl, precision (coefficient of variation) 5.4%, recovery 97.8% for phenobarbital, and there was good correlation with results obtained by gas-liquid chromatography and the EMIT system for phenobarbital. The authors recommend ultraviolet spectrophotometry as an excellent screening procedure for assessing the severity of barbiturate intoxication.

Barbiturates↗

A comparative study of the efficacy of four barbiturates as promoters of the development of gamma-glutamyltranspeptidase-positive foci in the liver of carcinogen treated rats.

The promoting action of four barbiturates, and their modulation of the promoting action of a choline-devoid (CD) diet was investigated by quantitating the gamma-glutamyltranspeptidase (GGT)-positive foci which developed in the liver of rats exposed to a single injection of diethylnitrosamine. Phenobarbital (PHB), pentobarbital (PTB) and amobarbital (AMB), exerted a promoting action, while barbituric acid (BA) had no effect. Addition of PHB or PTB to a CD diet resulted in a synergistic promoting action, but AMB had only an additive effect. Feeding a CD diet to rats caused a stimulation of liver DNA synthesis and of cell proliferation. These effects of the diet were markedly inhibited by addition of PHB or PTB, while addition of AMB resulted only in an inhibition of the enhanced proliferation of hepatocytes. No inhibitory effect was exerted by BA. The results indicate that the liver tumor promoting action of PHB and of barbiturates is dependent upon biological effects related to the presence of an alkyl group in their side chain. It is hypothesized that the promoting action of the agents herein studied may involve two components, a stimulation of the proliferation of initiated liver cells, and a suppression of the proliferation of non-initiated cells.

Animals↗

Rapid and selective determination of free barbiturates by gas chromatography using the electrolytic conductivity detector.

A rapid and specific gas chromatographic method for the analysis of free barbiturates in serum and urine at all levels of clinical interest is described. The method employs an improved electrolytic conductivity detector, and can be used for the determination of barbiturate levels of 0.01 mg/dl without sample clean-up. The preparation of columns for the analysis of nanogram quantities of free barbiturates is also discussed.

Autoanalysis↗

A collaborative study to investigate the retention reproducibility of barbiturates in HPLC with a view to establishing retention databases for drug identification.

A collaborative study among 10 laboratories has been undertaken to investigate the interlaboratory reproducibility of retention measurements in a high performance liquid chromatographic (HPLC) system for separating barbiturates. The system involved an ODS-Hypersil column with an eluent of methanol:phosphate buffer (40:60, v/v) at pH 8.5; all laboratories used the same batch of packing material. The conventional methods of recording retention properties (retention times and capacity factors) gave poor interlaboratory reproducibility. Better results were obtained by expressing the retentions relative to a standard barbiturate (quinalbarbitone); relative adjusted retention times proved to be more effective than straightforward relative retention times. Retention indices based on the alkylarylketone scale were not as reproducible as the methods based on a single closely related compound. The best reproducibility was obtained using corrected capacity factors based on the retention of four barbiturates in a standard mixture. The results of the study are discussed with a view to selecting the best methods of recording retention in HPLC when considering the establishment of databases for drug identification.

Barbiturates↗

Stability of barbiturates in fixed tissues and formalin solutions.

This study reports the results of the retention and quantitation of barbiturates in fresh tissue, in liver tissue fixed in formalin, and in the formalin solutions in which the same tissues were fixed for six months. Biological materials came from four cases of death due to phenobarbital and two due to butalbital. Results showed the presence of barbiturates in all studied materials. Mean recovery rates of phenobarbital in fixed liver were 57.11% and 30.84% in formalin from liver; and those of butalbital in fixed liver were 21.66% and 66.56% in formalin from liver. Total sums of recovery rates in formalin solutions and fixed tissues for phenobarbital (87.95%) and butalbital (88.22%) were comparable with those of the extraction efficiency of the method (90.2%) and indicate that these barbiturates have good stability even in biological specimens subjected to chemical fixation. This fact may be useful in qualitative evaluation of cases.

Autopsy↗

Flash alkylation for the identification of barbiturates in biological material.

The gas chromatographic identification of barbiturates isolated from biological material is not optimal, and due to their polar nature, it is difficult to obtain good resolution on most columns. To improve resolution, flash alkylation appeared to be a reasonable alternative. Methyl, ethyl, and butyl derivatives were prepared for various drugs found in the "acid-neutral" extract and the Kovats retention indices (Ir) were determined on SE-30, OV-17, and SP-2250. The Ir of the alkylated derivatives of the barbiturates are highly reproducible. One column and two alkylated derivatives can be used for the qualitative analysis of barbiturates in extracts of biological material, even when the Stas-Otto extract is used.

Alkylation↗

Brain intracellular pH, blood flow, and blood--brain barrier differences with barbiturate and halothane anesthesia in the cat.

The effects of various depths of barbiturate and halothane anesthesia and different arterial blood carbon dioxide tensions (PaCO2) at uniform levels of anesthesia on brain pH, tissue indicator perfusion, and blood flow were studied in 40 cats. Brain pH was measured using a lipid-soluble, pH-sensitive fluorescent indicator (umbelliferone), and its clearance was determined from the slope of its washout curve. Cerebral blood flow (CBF) was determined from the clearance of intra-arterially injected xenon-133. Values for CBF were higher in the halothane-exposed group, and with deep anesthesia they did not decrease as much as did those seen with pentobarbital (47 vs. 27 ml/100 g/min). The barbiturate brain pH-arterial blood PaCO2 regression line had a steeper slope than the corresponding halothane line. The two lines crossed at PaCO2 42 torr and brain pH 7.15. Brain pH was directly related to both PaCO2 and depth of anesthesia in the halothane-exposed group but only to PaCO2 in the barbiturate-exposed group. If light halothane anesthesia (0.1 per cent) can be considered almost equivalent to the waking state, then both anesthetics produce relative brain alkalinity. The clearance of the pH indicator was only modestly sensitive to changes in PaCO2 at anesthetic levels of pentobarbital and halothane. It was not significantly changed by increasing the amount of pentobarbital. However, increasing levels of halothane produced a decrease of more than 50 per cent in its clearance (63 ml/100 g/min at 0.1 per cent vs. 29 ml/100 g/min at 3 per cent). It is concluded that umbelliferone provides a reliable method for the measurement of brain pH and possibly a useful tool for studies of the blood-brain barrier.

Anesthesia, General↗

Evidence that barbiturates inhibit antigen-induced responses through interactions with a GTP-binding protein in rat basophilic leukemia (RBL-2H3) cells.

Little is known about the mechanism of action of anesthetics at the biochemical level. The present work, however, gives evidence that barbiturates inhibit inositol phospholipid hydrolysis in both intact and permeabilized rat basophilic leukemia (RBL-2H3) cells by an effect on GTP-binding proteins (G-proteins). Inhibition of hydrolysis was observed when intact cells were stimulated with antigen (DNP24 BSA) or with oligomers of IgE. The inhibition was dependent on the concentration and type of barbiturate used with an order of inhibitory action of secobarbital less than S(-) pentobarbital less than pentobarbital less than R(+) pentobarbital less than phenobarbital. The relatively inactive analogue, (1'RS, 3'SR) 3-hydroxypentobarbital caused little (less than 30% at 1 mM) or no inhibition (at 0.1-0.5 mM). In permeabilized cells, the hydrolysis induced by DNP24 BSA and the nonhydrolyzable analogue of GTP, GTP gamma S (2-100 microM), was also inhibited by pentobarbital. The inhibition of hydrolysis was decreased as pH increased, and was no longer apparent at pH 7.8, a possible indication that the inhibitory effect was due to the unionized form of the drug. In permeabilized cells, the inhibition by pentobarbital occurred in the presence or absence of Ca2+ and was uncompetitive in nature (Km = 7.1 microM for GTP in controls vs. 1.6 microM in the presence of 0.5 mM pentobarbital). Taken together, the data suggest that barbiturates alter the activity of G-proteins independently of Ca2+, and the inhibition may depend on both the hydrophobic properties and the stereospecific and structural features of the molecule.

Animals↗

Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.

Certain cytokines stimulate the expression of the inducible nitric oxide synthase (iNOS) in vascular smooth muscle cells (VSMCs) and in many other cell types. The large amounts of nitric oxide (NO) generated by iNOS in the vascular wall contribute to the unrelenting hypotension in septic shock. Because septic patients are often treated with barbiturates, we examined the effect of these anesthetic agents on the expression of iNOS in VSMCs. The induction of iNOS was elicited either in cultured rat aortic SMCs [interleukin-1beta (IL-1beta), 60 U/ml for 24 h] or in endothelium-denuded segments of the rabbit carotid artery [IL-1beta (100 U/ml) for 7 h]. The activity of iNOS was assessed by the accumulation of nitrite in the conditioned medium of cultured VSMCs and by the hyporeactivity of carotid arteries to phenylephrine. Moreover, iNOS protein abundance was determined by Western blot analysis, iNOS messenger RNA (mRNA) by reverse transcription followed by the polymerase chain reaction (PCR), and activation of the transcription factor NF-kappaB by gel electrophoretic mobility-shift analysis of nuclear extracts from VSMCs. The IL-1beta-stimulated increase in nitrite formation, iNOS protein, and mRNA abundance in VSMCs was significantly augmented in the presence of thiopental (100 microM), whereas methohexital, hexobarbital, pentobarbital, and phenobarbital were without effect. The potentiating effect of thiopental was observed only when the barbiturate was administered during the first 2 h of the 24-h incubation period of cultured VSMCs with IL-1beta. Thiopental did not affect the IL-1beta-stimulated activation of NF-kappaB in VSMCs. This barbiturate also significantly augmented the hyporeactivity to phenylephrine in carotid arteries exposed to IL-1beta, an effect that was abolished by N(G)-nitro-L-arginine. Exposure of either cultured or native VSMCs to thiopental alone did not stimulate iNOS expression. These findings demonstrate that the thiobarbiturate thiopental, but not oxybarbiturates, augments the IL-1beta-stimulated synthesis of NO in both cultured and native VSMCs. This effect of thiopental is the result of an increased expression of iNOS, involving most likely mechanisms distinct from NF-kappaB activation. The use of thiopental for long-term treatment of septic patients might possibly potentiate the biosynthesis of NO in the vascular wall and thus cause a further deterioration of the hemodynamic state.

Anesthetics, Intravenous↗